In8Bio Inc (INAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,498 | -10,644 | -5,550 | -30,437 | -24,277 |
| Depreciation Amortization | 1,980 | 1,453 | 669 | 2,655 | 1,953 |
| Accounts payable and accrued liabilities | -185 | -10 | 186 | -535 | 211 |
| Other Working Capital | -533 | 356 | 928 | -1,412 | -2,017 |
| Other Operating Activity | 2,663 | 1,796 | 645 | 5,580 | 4,009 |
| Operating Cash Flow | $-10,573 | $-7,049 | $-3,122 | $-24,149 | $-20,121 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -187 | -154 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-187 | $-154 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -582 | -459 | -225 | -794 | -575 |
| Common Stock Issued | 2,267 | 9,619 | 4,118 | 14,978 | 3,842 |
| Other Financing Activity | 8,464 | 0 | 0 | 0 | -270 |
| Financing Cash Flow | $10,149 | $9,160 | $3,893 | $14,184 | $2,997 |
| Beginning Cash Position | 11,386 | 11,386 | 11,386 | 21,538 | 21,538 |
| End Cash Position | 10,962 | 13,497 | 12,157 | 11,386 | 4,260 |
| Net Cash Flow | $-424 | $2,111 | $771 | $-10,152 | $-17,278 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,573 | -7,049 | -3,122 | -24,149 | -20,121 |
| Capital Expenditure | N/A | N/A | N/A | -187 | -154 |
| Free Cash Flow | -10,573 | -7,049 | -3,122 | -24,336 | -20,275 |